How the U.S. tax system stole $600B from Black Americans
April 24, 2024
Market Profile simplified with Jigsaw daytradr
May 17, 2024
China clouds darken market mood
May 19, 2024
Fokus auf Blutkrebsmedikament Pelabresib. Morphosys-CEO Jean-Paul Kress unterstützt den Deal Morphosys (MOR) – ISIN DE0006632003 Noch weitere Interessenten für Biotech-Unternehmen ...
Equity markets closed higher for the fifth consecutive day on Monday. The 30-share BSE Sensex rose 281 points to settle ...
TBE/iStock Editorial via Getty Images Update 2:03pm: Adds MorphoSys comment. MorphoSys (NASDAQ:MOR) ADRs quickly fell 4.5% amid speculation that Novartis ...
Bloomberg—Isomorphic Labs, a subsidiary of Alphabet Inc., said it entered into strategic research collaboration agreements with Novartis AG and Eli ...
© Reuters. FILE PHOTO: The company's logo is seen at a building of Swiss drugmaker Novartis in Rotkreuz, Switzerland, January ...
Novartis said in August that it plans to spin off its generics unit Sandoz to sharpen its focus on its ...
© Reuters. FILE PHOTO: ReNu contact lens solution by Bausch + Lomb, is seen for sale in Manhattan, New York ...
© Reuters. FILE PHOTO: The company's logo is seen at the new cell and gene therapy factory of Swiss drugmaker ...
© Reuters. FILE PHOTO: The company's logo is seen at the new cell and gene therapy factory of Swiss drugmaker ...
© Reuters. FILE PHOTO: The company's logo is seen at the new cell and gene therapy factory of Swiss drugmaker ...